SEC Filings

S-1/A
AVEXIS, INC. filed this Form S-1/A on 02/01/2016
Entire Document
 

Table of Contents

          Each $1.00 increase (decrease) in the assumed initial public offering price of $20.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash equivalents, additional paid in capital, total stockholders' equity and total capitalization by approximately $4.0 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1.0 million shares in the number of shares offered by us at the assumed initial public offering price per share of $20.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of additional paid in capital, total stockholders' equity (deficit) and total capitalization by approximately $18.6 million.

          The number of shares of our common stock issued and outstanding actual, pro forma and pro forma as adjusted excludes:

    1,750,794 shares of common stock issued pursuant to a restricted stock purchase agreement that, as of September 30, 2015, were subject to repurchase;

    1,583,521 shares of common stock issuable upon the exercise of outstanding stock options as of September 30, 2015, at a weighted-average exercise price of $13.99 per share, of which 69,000 shares have been issued upon exercise of such options subsequent to September 30, 2015;

    326,557 shares of common stock issuable upon the exercise of outstanding warrants as of September 30, 2015, at a weighted-average exercise price of $2.57 per share, which warrants are expected to remain outstanding at the consummation of this offering;

    up to a maximum of 424,932 shares of common stock reserved for future issuance under the 2014 Plan as of September 30, 2015, of which options to purchase 378,565 shares of our common stock were granted subsequent to September 30, 2015, at a weighted-average exercise price of $18.33; and

    2,400,000 shares of our common stock reserved for future issuance under our 2016 Plan, which will become effective upon the signing of the underwriting agreement in connection with this offering, as well as any automatic increases in the number of shares of common stock reserved for future issuance under this plan.

78



© AveXis, Inc. All Rights Reserved.